Study of Serum Tumor Markers in Diagnosing Pancreatic Cancer
Author Information
Author(s): P.A. Pasanen, M. Eskelinen, K. Partanen, P. Pikkarainen, I. Penttila, E. Alhaval
Primary Institution: University of Kuopio
Hypothesis
The study aims to assess the diagnostic value of various serum tumor markers in pancreatic cancer.
Conclusion
CA 50 and TPA are the best serum markers for predicting pancreatic malignancy.
Supporting Evidence
- CA 50 and TPA were identified as the best markers for pancreatic cancer.
- The study included 193 patients with various pancreatic conditions.
- Diagnostic scores were developed to improve the accuracy of cancer detection.
- High specificity was noted for the CA 50 and TPA tests.
Takeaway
Doctors looked at blood tests to see if they could tell if someone has pancreatic cancer, and found that two specific tests worked best.
Methodology
The study involved measuring serum values of tumor markers in patients with jaundice, cholestasis, or suspected pancreatic issues over a period of 21 years.
Limitations
The study had a low sensitivity for detecting pancreatic cancer despite high specificity.
Participant Demographics
Patients included those with jaundice, cholestasis, or suspected pancreatic tumors, aged 15 and older.
Statistical Information
P-Value
P<0.001 for CA 50, P<0.01 for TPA, P=0.07 for TPS, P=0.08 for CA 242, P=0.12 for CEA
Want to read the original?
Access the complete publication on the publisher's website